These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

879 related articles for article (PubMed ID: 31852635)

  • 21. Emerging Gastrointestinal and Liver Diseases in Asia Pacific: Implications to Health Care in the Region (World Gastroenterology Organization: Asian Pacific Association of Gastroenterology Distinguished Global Lecture 2015).
    Goh KL
    J Clin Gastroenterol; 2017 Jul; 51(6):479-485. PubMed ID: 28591070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Practical difficulties in the management of hepatitis B in the Asia-Pacific region.
    Mohamed R; Desmond P; Suh DJ; Amarapurkar D; Gane E; Guangbi Y; Hou JL; Jafri W; Lai CL; Lee CH; Lee SD; Lim SG; Guan R; Phiet PH; Piratvisuth T; Sollano J; Wu JC
    J Gastroenterol Hepatol; 2004 Sep; 19(9):958-69. PubMed ID: 15304110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Burden of non-alcoholic fatty liver disease in Asia, the Middle East and North Africa: Data from Global Burden of Disease 2009-2019.
    Golabi P; Paik JM; AlQahtani S; Younossi Y; Tuncer G; Younossi ZM
    J Hepatol; 2021 Oct; 75(4):795-809. PubMed ID: 34081959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatology after Hepatitis C.
    Fitz JG
    Dig Dis; 2016; 34(5):603-6. PubMed ID: 27332966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. China's efforts to shed its title of "Leader in liver disease".
    Li X; Xu WF
    Drug Discov Ther; 2007 Oct; 1(2):84-5. PubMed ID: 22504391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overview of hepatitis B prevalence, prevention, and management in the Pacific Islands and Territories.
    Howell J; Van Gemert C; Lemoine M; Thursz M; Hellard M
    J Gastroenterol Hepatol; 2014 Nov; 29(11):1854-66. PubMed ID: 25131570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B and hepatitis C in southeast and southern Asia: challenges for governments.
    Wait S; Kell E; Hamid S; Muljono DH; Sollano J; Mohamed R; Shah S; Mamun-Al-Mahtab ; Abbas Z; Johnston J; Tanwandee T; Wallace J
    Lancet Gastroenterol Hepatol; 2016 Nov; 1(3):248-255. PubMed ID: 28404097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The future liver of the Asia pacific: fatter and firmer from more fructose and fortune?
    Mahady SE; George J
    J Clin Exp Hepatol; 2013 Jun; 3(2):106-13. PubMed ID: 25755484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatocellular carcinoma in the Asia pacific region.
    Yuen MF; Hou JL; Chutaputti A;
    J Gastroenterol Hepatol; 2009 Mar; 24(3):346-53. PubMed ID: 19220670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver diseases and hepatocellular carcinoma in the Asia-Pacific region: burden, trends, challenges and future directions.
    Mak LY; Liu K; Chirapongsathorn S; Yew KC; Tamaki N; Rajaram RB; Panlilio MT; Lui R; Lee HW; Lai JC; Kulkarni AV; Premkumar M; Lesmana CRA; Hsu YC; Huang DQ
    Nat Rev Gastroenterol Hepatol; 2024 Dec; 21(12):834-851. PubMed ID: 39147893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Minderoo-Monaco Commission on Plastics and Human Health.
    Landrigan PJ; Raps H; Cropper M; Bald C; Brunner M; Canonizado EM; Charles D; Chiles TC; Donohue MJ; Enck J; Fenichel P; Fleming LE; Ferrier-Pages C; Fordham R; Gozt A; Griffin C; Hahn ME; Haryanto B; Hixson R; Ianelli H; James BD; Kumar P; Laborde A; Law KL; Martin K; Mu J; Mulders Y; Mustapha A; Niu J; Pahl S; Park Y; Pedrotti ML; Pitt JA; Ruchirawat M; Seewoo BJ; Spring M; Stegeman JJ; Suk W; Symeonides C; Takada H; Thompson RC; Vicini A; Wang Z; Whitman E; Wirth D; Wolff M; Yousuf AK; Dunlop S
    Ann Glob Health; 2023; 89(1):23. PubMed ID: 36969097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of hepatocellular carcinoma in a community-based Taiwanese population without chronic HBV/HCV infection.
    Wu HC; Jeng WJ; Pan MH; Hsieh YC; Lu SN; Chen CJ; Yang HI
    JHEP Rep; 2022 Feb; 4(2):100410. PubMed ID: 35079699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changing epidemiology of liver disease in Asia: Dual infection of HBV and HCV.
    Liu CJ; Chen PJ
    Liver Int; 2022 Aug; 42(9):1945-1954. PubMed ID: 34402183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gathering momentum for the way ahead: fifth report of the Lancet Standing Commission on Liver Disease in the UK.
    Williams R; Alexander G; Aspinall R; Batterham R; Bhala N; Bosanquet N; Severi K; Burton A; Burton R; Cramp ME; Day N; Dhawan A; Dillon J; Drummond C; Dyson J; Ferguson J; Foster GR; Gilmore I; Greenberg J; Henn C; Hudson M; Jarvis H; Kelly D; Mann J; McDougall N; McKee M; Moriarty K; Morling J; Newsome P; O'Grady J; Rolfe L; Rice P; Rutter H; Sheron N; Thorburn D; Verne J; Vohra J; Wass J; Yeoman A
    Lancet; 2018 Dec; 392(10162):2398-2412. PubMed ID: 30473364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NIH consensus development statement on management of hepatitis B.
    Belongia EA; Costa J; Gareen IF; Grem JL; Inadomi JM; Kern ER; McHugh JA; Petersen GM; Rein MF; Sorrell MF; Strader DB; Trotter HT
    NIH Consens State Sci Statements; 2008 Oct 22-24; 25(2):1-29. PubMed ID: 18949020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of standardised assessment forms in referrals to hepatology outpatient services: implications for accurate triaging of patients with chronic hepatitis C.
    Horsfall L; Macdonald G; Scott I; Skoien R; Khatun M; Moss C; Seligman C; Kardash C; Poxon V; Powell EE
    Aust Health Rev; 2013 May; 37(2):218-22. PubMed ID: 23448666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reimbursement policies in the Asia-Pacific for chronic hepatitis B.
    Lim SG; Amarapurkar DN; Chan HL; Crawford DH; Gane EJ; Han KH; Ahn SH; Jafri W; Jia J; Kao JH; Lesmana LA; Lesmana CR; Mohamed R; Phiet PH; Piratvisuth T; Sarin SK; Sollarno JD; Eguchi Y; Mahtab MA; Lee KH
    Hepatol Int; 2015 Jan; 9(1):43-51. PubMed ID: 25788378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aiming for the elimination of viral hepatitis in Australia, New Zealand, and the Pacific Islands and Territories: Where are we now and barriers to meeting World Health Organization targets by 2030.
    Howell J; Pedrana A; Cowie BC; Doyle J; Getahun A; Ward J; Gane E; Cunningham C; Wallace J; Lee A; Malani J; Thompson A; Hellard ME
    J Gastroenterol Hepatol; 2019 Jan; 34(1):40-48. PubMed ID: 30151932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How many deaths are caused by non-alcoholic fatty liver disease in the Asia-Pacific region?
    Wong GL; Wong VW
    Lancet Gastroenterol Hepatol; 2020 Feb; 5(2):103-105. PubMed ID: 31852632
    [No Abstract]   [Full Text] [Related]  

  • 40. Burden of non-communicable diseases among adolescents and young adults aged 10-24 years in the South-East Asia and Western Pacific regions, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
    Wang H; Song Y; Ma J; Ma S; Shen L; Huang Y; Thangaraju P; Basharat Z; Hu Y; Lin Y; Peden AE; Sawyer SM; Zhang H; Zou Z
    Lancet Child Adolesc Health; 2023 Sep; 7(9):621-635. PubMed ID: 37524095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.